Literature DB >> 24161883

Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics.

Jacklyn N Hellwege1, Nicholette D Palmer, Julie T Ziegler, Carl D Langefeld, Carlos Lorenzo, Jill M Norris, Toshinari Takamura, Donald W Bowden.   

Abstract

CONTEXT: Insulin resistance is not fully explained on a molecular level, though several genes and proteins have been tied to this defect. Knockdowns of the SEPP1 gene, which encodes the selenoprotein P (SeP) protein, have been shown to increase insulin sensitivity in mice. SeP is a liver-derived plasma protein and a major supplier of selenium, which is a proposed insulin mimetic and antidiabetic agent.
OBJECTIVE: SEPP1 single nucleotide polymorphisms (SNPs) were selected for analysis with glucometabolic measures. PARTICIPANTS AND MEASURES: The study included1424 Hispanics from families in the Insulin Resistance Atherosclerosis Family Study (IRASFS). Additionally, the multi-ethnic Insulin Resistance Atherosclerosis Study was used. A frequently sampled intravenous glucose tolerance test was used to obtain precise measures of acute insulin response (AIR) and the insulin sensitivity index (SI).
DESIGN: 21 SEPP1 SNPs (tagging SNPs (n=12) from HapMap, 4 coding variants and 6 SNPs in the promoter region) were genotyped and analyzed for association.
RESULTS: Two highly correlated (r(2)=1) SNPs showed association with AIR (rs28919926; Cys368Arg; p=0.0028 and rs146125471; Ile293Met; p=0.0026) while rs16872779 (intronic) was associated with fasting insulin levels (p=0.0097). In the smaller IRAS Hispanic cohort, few of the associations seen in the IRASFS were replicated, but meta-analysis of IRASFS and all 3 IRAS cohorts (N=2446) supported association of rs28919926 and rs146125471 with AIR (p=0.013 and 0.0047, respectively) as well as rs7579 with SI (p=0.047).
CONCLUSIONS: Overall, these results in a human sample are consistent with the literature suggesting a role for SEPP1 in insulin resistance.
© 2013.

Entities:  

Keywords:  AA; AIR; Acute Insulin Response; Acute insulin response (AIR); African American; ApoB; Apolipoprotein B; BMI; Body Mass Index; DI; Disposition Index; EA; European American; FSIGT; Fibrinogen; Frequently Sampled Intravenous Glucose Tolerance Test; HA; HDL; HOMA-IR; High-density Lipoprotein; Hispanic American; Hispanic Americans; Homeostasis model assessment of insulin resistance; IL6; IRAS; IRASFS; Insulin Resistance Atherosclerosis Family Study; Insulin Resistance Atherosclerosis Study; Insulin Sensitivity Index; Insulin resistance; Interleukin 6; LDL; Low-density Lipoprotein; MAF; MCRI; Metabolic Clearance Rate of Insulin; Minor Allele Frequency; PAI-1; Plasminogen Activator Inhibitor-1; S(I); SAT; SNP; SOLAR; SeP; Selenium; Selenoprotein P; Selenoproteins; Sequential Oligogenic Linkage Analysis Routines; Single Nucleotide Polymorphism; Subcutaneous Adipose Tissue; T2D; TNF; Tumor Necrosis Factor; Type 2 Diabetes Mellitus; UTR; VAT; Visceral Adipose Tissue; WHR; Waist:Hip ratio; untranslated region

Mesh:

Substances:

Year:  2013        PMID: 24161883      PMCID: PMC3856675          DOI: 10.1016/j.gene.2013.10.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  43 in total

1.  Associations of selenium status with cardiometabolic risk factors: an 8-year follow-up analysis of the Olivetti Heart study.

Authors:  Saverio Stranges; Ferruccio Galletti; Eduardo Farinaro; Lanfranco D'Elia; Ornella Russo; Roberto Iacone; Clemente Capasso; Vincenzo Carginale; Viviana De Luca; Elisabetta Della Valle; Francesco P Cappuccio; Pasquale Strazzullo
Journal:  Atherosclerosis       Date:  2011-03-30       Impact factor: 5.162

2.  Effectiveness of selenium supplements in a low-selenium area of China.

Authors:  Yiming Xia; Kristina E Hill; Daniel W Byrne; Jiayuan Xu; Raymond F Burk
Journal:  Am J Clin Nutr       Date:  2005-04       Impact factor: 7.045

3.  Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study.

Authors:  G Bruno; P Cavallo-Perin; G Bargero; M Borra; N D'Errico; G Macchia; G Pagano
Journal:  Diabetes Metab Res Rev       Date:  2001 Mar-Apr       Impact factor: 4.876

Review 4.  The influence of selenium and selenoprotein gene variants on colorectal cancer risk.

Authors:  Catherine Méplan; John Hesketh
Journal:  Mutagenesis       Date:  2012-03       Impact factor: 3.000

5.  Multiple forms of selenoprotein P in a candidate human plasma standard reference material.

Authors:  Guillaume Ballihaut; Lisa E Kilpatrick; Eric L Kilpatrick; W Clay Davis
Journal:  Metallomics       Date:  2012-05-03       Impact factor: 4.526

6.  Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation.

Authors:  Yuanyuan Zhang; Xiaoli Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

7.  Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.

Authors:  Yumie Takata; Irena B King; Johanna W Lampe; Raymond F Burk; Kristina E Hill; Regina M Santella; Alan R Kristal; David J Duggan; Thomas L Vaughan; Ulrike Peters
Journal:  J Nutr       Date:  2012-01-18       Impact factor: 4.798

8.  Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.

Authors:  N D Palmer; C D Langefeld; J T Ziegler; F Hsu; S M Haffner; T Fingerlin; J M Norris; Y I Chen; S S Rich; T Haritunians; K D Taylor; R N Bergman; J I Rotter; D W Bowden
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

9.  Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes.

Authors:  Hirofumi Misu; Kazuhide Ishikura; Seiichiro Kurita; Yumie Takeshita; Tsuguhito Ota; Yoshiro Saito; Kazuhiko Takahashi; Shuichi Kaneko; Toshinari Takamura
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

Review 10.  The relationship between selenoprotein P and glucose metabolism in experimental studies.

Authors:  Jinyuan Mao; Weiping Teng
Journal:  Nutrients       Date:  2013-05-29       Impact factor: 5.717

View more
  22 in total

Review 1.  Selenium in thyroid disorders - essential knowledge for clinicians.

Authors:  Kristian Hillert Winther; Margaret Philomena Rayman; Steen Joop Bonnema; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2020-01-30       Impact factor: 43.330

2.  Diet-induced obesity in the selenocysteine lyase knockout mouse.

Authors:  Lucia A Seale; Christy L Gilman; Ann C Hashimoto; Ashley N Ogawa-Wong; Marla J Berry
Journal:  Antioxid Redox Signal       Date:  2015-08-24       Impact factor: 8.401

Review 3.  Selenium: an element for life.

Authors:  Leonidas H Duntas; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-12-18       Impact factor: 3.633

Review 4.  Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology.

Authors:  Francesca Gorini; Cristina Vassalle
Journal:  Antioxidants (Basel)       Date:  2022-06-16

5.  High Dietary Selenium Intake Alters Lipid Metabolism and Protein Synthesis in Liver and Muscle of Pigs.

Authors:  Zeping Zhao; Matthew Barcus; Jonggun Kim; Krystal L Lum; Courtney Mills; Xin Gen Lei
Journal:  J Nutr       Date:  2016-07-27       Impact factor: 4.798

6.  A genome-wide linkage and association analysis of imputed insertions and deletions with cardiometabolic phenotypes in Mexican Americans: The Insulin Resistance Atherosclerosis Family Study.

Authors:  Chuan Gao; Fang-Chi Hsu; Latchezar M Dimitrov; Hayrettin Okut; Yii-Der I Chen; Kent D Taylor; Jerome I Rotter; Carl D Langefeld; Donald W Bowden; Nicholette D Palmer
Journal:  Genet Epidemiol       Date:  2017-04-05       Impact factor: 2.344

Review 7.  Selenium and chronic diseases: a nutritional genomics perspective.

Authors:  Catherine Méplan
Journal:  Nutrients       Date:  2015-05-15       Impact factor: 5.717

8.  SEPP1 gene variants and abdominal aortic aneurysm: gene association in relation to metabolic risk factors and peripheral arterial disease coexistence.

Authors:  Ewa Strauss; Grzegorz Oszkinis; Ryszard Staniszewski
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

Review 9.  Implication of hepatokines in metabolic disorders and cardiovascular diseases.

Authors:  Tae Woo Jung; Hye Jin Yoo; Kyung Mook Choi
Journal:  BBA Clin       Date:  2016-03-05

Review 10.  Selenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes Risk.

Authors:  Ashley N Ogawa-Wong; Marla J Berry; Lucia A Seale
Journal:  Nutrients       Date:  2016-02-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.